PAVmed Historical Balance Sheet
PAVM Stock | USD 0.97 0.03 3.19% |
Trend analysis of PAVmed Inc balance sheet accounts such as Accounts Payable of 1.9 M, Cash of 18.9 M, Cash And Short Term Investments of 18.9 M or Common Stock Total Equity of 103.8 K provides information on PAVmed's total assets, liabilities, and equity, which is the actual value of PAVmed Inc to its prevalent stockholders. By breaking down trends over time using PAVmed balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining PAVmed Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PAVmed Inc is a good buy for the upcoming year.
PAVmed Inventory |
|
PAVmed |
About PAVmed Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of PAVmed Inc at a specified time, usually calculated after every quarter, six months, or one year. PAVmed Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PAVmed and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PAVmed currently owns. An asset can also be divided into two categories, current and non-current.
PAVmed Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of PAVmed assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PAVmed Inc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on PAVmed balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PAVmed Inc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Total Liab
The total amount of all liabilities that a company has, including both short-term and long-term liabilities.Most accounts from PAVmed's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PAVmed Inc current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At this time, PAVmed's Other Stockholder Equity is very stable compared to the past year. As of the 1st of December 2024, Total Liabilities is likely to grow to about 60 M, though Total Stockholder Equity is likely to grow to (51.1 M).
2021 | 2022 | 2023 | 2024 (projected) | Cash | 77.3M | 39.7M | 19.6M | 18.9M | Accounts Payable | 3.3M | 2.7M | 1.8M | 1.9M |
PAVmed balance sheet Correlations
Click cells to compare fundamentals
PAVmed Account Relationship Matchups
High Positive Relationship
High Negative Relationship
PAVmed balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 7.2M | 19.8M | 87.0M | 54.0M | 33.1M | 23.6M | |
Other Current Liab | 1.4M | (15.0M) | 4.3M | 3.7M | 6.6M | 7.0M | |
Total Current Liabilities | 11.9M | 20.0M | 7.6M | 41.2M | 54.2M | 56.9M | |
Total Stockholder Equity | (3.8M) | 1.9M | 61.7M | (9.7M) | (53.8M) | (51.1M) | |
Net Tangible Assets | (6.1M) | (641K) | 57.2M | (15.8M) | (18.2M) | (17.3M) | |
Net Debt | 1.9M | (2.3M) | (77.3M) | (3.1M) | 29.1M | 30.5M | |
Retained Earnings | (53.7M) | (88.3M) | (138.9M) | (228.2M) | (294.4M) | (279.7M) | |
Accounts Payable | 2.4M | 3.0M | 3.3M | 2.7M | 1.8M | 1.9M | |
Cash | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 18.9M | |
Cash And Short Term Investments | 6.2M | 17.3M | 77.3M | 39.7M | 19.6M | 18.9M | |
Common Stock Total Equity | 27.1K | 40.5K | 64K | 86K | 98.9K | 103.8K | |
Common Stock Shares Outstanding | 2.0M | 3.2M | 5.2M | 5.9M | 7.2M | 6.9M | |
Liabilities And Stockholders Equity | 7.2M | 19.8M | 87.0M | 54.0M | 33.1M | 23.6M | |
Capital Surpluse | 32.6M | 47.6M | 87.6M | 198.1M | 227.8M | 239.2M | |
Other Current Assets | 328.3B | 1.7M | 5.2M | 3.9M | 3.8M | 3.6M | |
Other Stockholder Equity | 47.6M | 87.6M | 198.1M | 215.9M | 237.6M | 249.5M | |
Total Liab | 11.9M | 20.3M | 7.6M | 43.0M | 57.1M | 60.0M | |
Total Current Assets | 6.5M | 18.9M | 82.6M | 43.9M | 24.5M | 20.8M | |
Common Stock | 40.5K | 64K | 86K | 95K | 9K | 8.6K | |
Non Current Assets Total | 692.9K | 837K | 4.3M | 10.1M | 8.6M | 9.1M | |
Non Currrent Assets Other | 692.9K | 755K | 725K | 1.1M | 1.1M | 614.4K | |
Other Assets | 693K | 837K | 725K | 1.1M | 1.0 | 0.95 | |
Non Current Liabilities Total | 10.5M | 300K | 4.3B | 1.8M | 3.0M | 2.8M | |
Noncontrolling Interest In Consolidated Entity | (161.5K) | (814.3K) | (2.4M) | 17.8M | 20.4M | 21.4M | |
Retained Earnings Total Equity | (37.0M) | (53.7M) | (88.3M) | (138.9M) | (125.0M) | (118.8M) | |
Short Term Investments | 34K | 262K | 2.0M | 3.0M | 2.7M | 2.8M | |
Preferred Stock Total Equity | 2.0M | 2.3M | 2.5M | 2.4M | 2.8M | 1.9M | |
Property Plant Equipment | 692.9K | 82K | 1.6M | 5.5M | 6.3M | 6.6M | |
Short Long Term Debt Total | 7.9M | 8.1M | 15.0M | 36.6M | 48.7M | 51.2M | |
Net Invested Capital | 2.0M | 14.3M | 59.2M | 21.3M | (12.6M) | (12.0M) | |
Short Long Term Debt | 7.9M | 8.1M | 14.7M | 33.7M | 44.2M | 46.4M | |
Net Working Capital | (5.3M) | (1.0M) | 75.1M | 2.7M | (29.7M) | (28.2M) | |
Short Term Debt | 7.9M | 8.1M | 15.0M | 34.8M | 45.8M | 48.1M | |
Capital Stock | 2.3M | 2.6M | 2.5M | 2.8M | 3.0M | 2.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PAVmed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PAVmed. If investors know PAVmed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PAVmed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Revenue Per Share 0.459 | Quarterly Revenue Growth 4.898 | Return On Assets (0.80) | Return On Equity (13.58) |
The market value of PAVmed Inc is measured differently than its book value, which is the value of PAVmed that is recorded on the company's balance sheet. Investors also form their own opinion of PAVmed's value that differs from its market value or its book value, called intrinsic value, which is PAVmed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PAVmed's market value can be influenced by many factors that don't directly affect PAVmed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between PAVmed's value and its price as these two are different measures arrived at by different means. Investors typically determine if PAVmed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PAVmed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.